Global Senior Oncology Clinical Trials Lead

Summit Therapeutics, Inc.; United States; Presencial; USD 158.000 - 185.000; Jornada completa

Descripción de la vacante

Summit Therapeutics Inc. in the United States seeks a Senior Clinical Trial Manager to provide strategic leadership and operational oversight of complex global oncology trials, from protocol development through study closeout.

You will mentor CTMs and CRAs, manage CRO relationships, ensure GCP/ICH compliance, quality plans, and data systems while driving enrollment strategies and risk mitigation. Travel up to 20% is required.

Formación

• 8–10+ years in clinical operations for pharmaceutical/biotech.
• 7+ years managing phase II/III international oncology trials.
• Ability to travel internationally up to 20%.
• Proficient interpretation of complex clinical data for trial decisions.
• Experience supervising CROs and in-house teams.

Responsabilidades

• Oversee site selection, feasibility, activation, enrollment, monitoring, issue escalation and closeout.
• Provide strategic leadership and operational oversight of global trials from start-up through closeout.
• Draft and approve study documents, plans, and data management activities.
• Lead risk-based quality management and inspection readiness.
• Mentor CTMs, CRAs, and other Clinical Operations staff.
• Manage CRO relationships and ensure high-quality study execution.

Conocimientos

Clinical Operations Leadership

Global Trial Management

Team Leadership

Data Review & Decision Making

CRO Oversight

ICH/GCP Knowledge

Study Start-Up & Activation

Site Management

Educación

Bachelor’s degree in life sciences or related field

Descripción del empleo

Summit Therapeutics Inc. in the United States seeks a Senior Clinical Trial Manager to provide strategic leadership and operational oversight of complex global oncology trials, from protocol development through study closeout.

You will mentor CTMs and CRAs, manage CRO relationships, ensure GCP/ICH compliance, quality plans, and data systems while driving enrollment strategies and risk mitigation. Travel up to 20% is required.